1.
Zhang J. Efficacy of Combined SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Managing Diabetic Nephropathy. Med. Insights [Internet]. 2025 Nov. 7 [cited 2026 May 12];2(4):24-35. Available from: https://soapubs.com/index.php/MI/article/view/1835